Evolution and Prognostic Significance of Patient-Reported Symptoms After Intervention in Severe Aortic Stenosis
- PMID: 38432746
- DOI: 10.1016/j.mayocp.2023.09.024
Evolution and Prognostic Significance of Patient-Reported Symptoms After Intervention in Severe Aortic Stenosis
Abstract
Objective: To describe the evolution of symptoms in patients with symptomatic severe aortic stenosis (sSAS) undergoing valve replacement, the predictors of the persistence of these symptoms, and their prognostic significance. The evolution of symptoms after intervention in sSAS and their association with outcome are unknown.
Patients and methods: Data from patients with sSAS who underwent intervention were collected. All-cause mortality and cardiovascular mortality were considered events. The evolution of symptoms and their association with events were studied.
Results: In this study, 451 consecutive patients with sSAS and no other valvular or coronary disease who were alive 30 days after intervention were included. Before valve replacement, 133 of the 451 patients (29.5%) had congestive heart failure requiring hospitalization. Of the remaining 318 patients, 287 (90.2%) had dyspnea on effort, 129 (40.6%) had angina, and 59 had syncope (18.6%). Symptoms disappeared after intervention in 192 of the 451 patients (42.6%) and remained in 259 (57.4%): 193 dyspnea, 9 angina, 17 syncope, and 60 admission for heart failure. Syncope on effort persisted in 4 of 33 patients (12.1%) and at rest in 11 of 20 (55.0%; P<.001). Age, body mass index, previous admission for heart failure, and chronic obstructive pulmonary disease were independently related to persistence of symptoms. Over a median follow-up of 56 months in our cohort of 451 patients, 129 deaths were registered (28.6%), 40 of which were cardiovascular (8.9%). Age, chronic obstructive pulmonary disease, chronic kidney disease, atrial fibrillation, heart failure, and persistence of symptoms were independently associated with all-cause mortality.
Conclusion: Symptoms attributed to SAS remain after intervention in a high proportion of patients, particularly dyspnea on effort and syncope at rest. The persistence of symptoms after intervention identifies patients with poor outcome.
Copyright © 2023 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Recurrence of syncope after valve replacement in severe aortic stenosis.Heart. 2023 Oct 12;109(21):1631-1638. doi: 10.1136/heartjnl-2023-322859. Heart. 2023. PMID: 37286345
-
Syncope: The Underestimated Threat in Severe Aortic Stenosis.JACC Cardiovasc Imaging. 2019 Feb;12(2):225-232. doi: 10.1016/j.jcmg.2018.09.020. Epub 2018 Dec 12. JACC Cardiovasc Imaging. 2019. PMID: 30553685
-
Clinical factors associated with classical symptoms of aortic valve stenosis.J Heart Valve Dis. 2013 May;22(3):287-94. J Heart Valve Dis. 2013. PMID: 24151753
-
[The best of valvular heart disease in 2006].Arch Mal Coeur Vaiss. 2007 Jan;100 Spec No 1:19-28. Arch Mal Coeur Vaiss. 2007. PMID: 17405561 Review. French.
-
Asymptomatic aortic stenosis in the elderly: a clinical review.JAMA. 2013 Oct 9;310(14):1490-7. doi: 10.1001/jama.2013.279194. JAMA. 2013. PMID: 24104373 Review.
Cited by
-
Sex Differences in Clinical Outcomes after Aortic Valve Intervention for Isolated Severe Aortic Stenosis.J Clin Med. 2023 Nov 10;12(22):7025. doi: 10.3390/jcm12227025. J Clin Med. 2023. PMID: 38002639 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
